Supplementation with ResistAid™ found to support the body's immune defenses against respiratory tract infections

摘要

A research study published this month found thatsupplementation with Lonza's proprietary immune support ingredient ResistAid™ wasassociated with a statistically significant reduction (-23%) of the number of cold episodes incomparison with placebo. In addition, the percentage of study days that participants did not suffer from any cold symptoms was significantly higher in the group taking larch arabinogalactan (91.2%) compared to the placebo group (88.5%).